| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,090 |
4,968 |
$476K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,655 |
1,609 |
$228K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
681 |
659 |
$110K |
| 87428 |
|
1,288 |
1,264 |
$27K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
213 |
203 |
$9K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
152 |
148 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,483 |
1,402 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
288 |
280 |
$4K |
| 82550 |
|
845 |
795 |
$3K |
| 80051 |
|
825 |
780 |
$3K |
| 82565 |
|
825 |
780 |
$3K |
| 84520 |
|
825 |
780 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
213 |
203 |
$2K |
| 82947 |
|
896 |
813 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12 |
12 |
$2K |
| 80053 |
Comprehensive metabolic panel |
251 |
235 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
262 |
261 |
$1K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
229 |
209 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
104 |
98 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
60 |
58 |
$1K |
| 84484 |
|
189 |
160 |
$1K |
| 81025 |
|
499 |
485 |
$1K |
| 70450 |
Computed tomography, head or brain; without contrast material |
24 |
24 |
$1K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
41 |
40 |
$943.20 |
| 71046 |
Radiologic examination, chest; 2 views |
95 |
94 |
$941.48 |
| 81003 |
|
553 |
537 |
$905.79 |
| 71045 |
Radiologic examination, chest; single view |
157 |
150 |
$822.22 |
| 82977 |
|
97 |
95 |
$623.14 |
| 84460 |
|
97 |
95 |
$457.57 |
| 84450 |
|
97 |
95 |
$453.08 |
| 82247 |
|
97 |
95 |
$440.36 |
| 84075 |
|
97 |
95 |
$405.16 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
73 |
72 |
$360.00 |
| 82150 |
|
97 |
95 |
$334.67 |
| 84155 |
|
97 |
95 |
$296.94 |
| 82040 |
|
97 |
95 |
$233.51 |
| 83605 |
|
40 |
39 |
$168.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
189 |
161 |
$157.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$140.35 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
16 |
$101.60 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12 |
12 |
$56.00 |
| 85379 |
|
12 |
12 |
$31.80 |
| 87420 |
|
14 |
14 |
$0.00 |